"The other big drug problem: Older people taking too many pills" "The side effects of drugs are frequently misinterpreted as a new problem, triggering more prescriptions, a process known as a prescribing cascade"https://www.washingtonpost.com/national/health-science/the-other-big-drug-problem-older-people-taking-too-many-pills/2017/12/08/3cea5ca2-c30a-11e7-afe9-4f60b5a6c4a0_story.html?tid=sm_tw&utm_term=.87cf92851757 …
Is it as simple as a proper, quality drug review? Or is there more than meets the eye?
-
-
It's actively asking "why should I continue this" rather than just clarifying you have the list right and ticking all the continue boxes. Old and frail patients are hammered by drugs they previously tolerated easily
-
I'm all in favour of that. I have enough misgivings about individual pharma drugs as it is. This polypharmacy issue doesn't help. How well are reviews done, would you say?
-
Depends who does them. In GP land I don't know, I do on all admissions and again on discharge. Quality is dependant on seniority of reviewer, and availability of pharmacists. Young docs loathe to stop meds someone else started and tend to add even more. Older docs stop.
-
Interesting. Sounds like an opportunity for multiple wins. Patients, doctors, budgets. Big pharma not so much, but they do well enough. Worth its own specialist role? I'm sure someone, somewhere's already way ahead of me on that.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.